RVPIX
Price
$10.24
Change
+$0.07 (+0.69%)
Updated
Sep 11 closing price
Net Assets
228.4M
VSGIX
Price
$95.95
Change
+$0.82 (+0.86%)
Updated
Sep 11 closing price
Net Assets
44.71B
Interact to see
Advertisement

RVPIX vs VSGIX

RVPIX vs VSGIX Comparison Chart in %
View a ticker or compare two or three
VS
RVPIX vs. VSGIX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVPIX is a Hold and VSGIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 44.7B vs. RVPIX (228M). RVPIX pays higher dividends than VSGIX: RVPIX (1.45) vs VSGIX (0.44). RVPIX was incepted earlier than VSGIX: RVPIX (20 years) vs VSGIX (26 years). RVPIX (1.50) is less costly to investors than VSGIX (0.05). RVPIX is a more actively managed with annual turnover of: 75.00 vs. VSGIX (24.00). RVPIX has a lower initial minimum investment than VSGIX: RVPIX (1000000) vs VSGIX (5000000). RVPIX annual gain was more profitable for investors over the last year : 15.51 vs. VSGIX (12.29). VSGIX return over 5 years is better than : 17.58 vs. RVPIX (-17.78).
RVPIXVSGIXRVPIX / VSGIX
Total Expense Ratio1.020.052,040%
Annual Report Gross Expense Ratio1.500.053,000%
Fund Existence20 years26 years-
Gain YTD24.27212.014202%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets228M44.7B1%
Annual Yield % from dividends1.450.44327%
Returns for 1 year15.5112.29126%
Returns for 3 years66.1251.13129%
Returns for 5 years-17.7817.58-101%
Returns for 10 years-7.19168.27-4%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFMIX21.62N/A
N/A
Hartford MidCap I
IGHSX13.14N/A
N/A
Voya Global High Dividend Low Vol Port S
PWDCX12.42N/A
N/A
DF Tactical Dividend Fund C
HFDTX21.85N/A
N/A
Hartford Schroders US MidCap Opps R5
JGRJX37.47N/A
N/A
JPMorgan Growth Advantage R2